title: [Rational imaging in locally advanced prostate cancer].
abstract: Prostate cancer is one of the principal medical problems facing the male population in developed countries with an increasing need for sophisticated imaging techniques and risk-adapted treatment options. This article presents an overview of the current imaging procedures in the diagnosis of locally advanced prostate cancer. Apart from conventional gray-scale transrectal ultrasound (TRUS) as the most frequently used primary imaging modality we describe computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). CT and MRI not only allow assessment of prostate anatomy but also a specific evaluation of the pelvic region. Color-coded and contrast-enhanced ultrasound, real-time elastography, dynamic contrast enhancement in MR imaging, diffusion imaging, and MR spectroscopy may lead to a clinically relevant improvement in the diagnosis of prostate cancer. While bone scintigraphy with (99m)Tc-bisphosphonates is still the method of choice in the evaluation of bone metastasis, whole-body MRI and PET using (18)F-NaF, (18)F-FDG, (11)C-choline, (11)C-acetate, and (18)F-choline as tracers achieve higher sensitivities.
authors.affiliation: Institut für Röntgendiagnostik, Julius-Maximilians-Universität, Oberdürrbacher Strasse 6, 97080, Würzburg, Deutschland. beissert@roentgen.uni-wuerzburg.de
authors.forename: M
authors.initials: M
authors.lastname: Beissert
authors.forename: R
authors.initials: R
authors.lastname: Lorenz
authors.forename: E W
authors.initials: EW
authors.lastname: Gerharz
mesh_terms: D001859:Bone Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000556:secondary; D001842:Bone and Bones / Q000473:pathology; D003952:Diagnostic Imaging; D006801:Humans; D007089:Image Enhancement; D007091:Image Processing, Computer-Assisted; D008297:Male; D009367:Neoplasm Staging; D011467:Prostate / Q000473:pathology; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology; D012680:Sensitivity and Specificity; D013125:Spinal Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000556:secondary; D013131:Spine / Q000473:pathology
references.citation: Cancer. 1999 Apr 1;85(7):1577-85
references.pmid: 10193949
references.citation: Eur J Nucl Med. 2001 Nov;28(11):1707-23
references.pmid: 11702115
references.citation: J Magn Reson Imaging. 2006 Feb;23(2):130-4
references.pmid: 16374882
references.citation: Nuklearmedizin. 2007;46(5):161-8; quiz N47-8
references.pmid: 17938748
references.citation: J Nucl Med. 1998 Jun;39(6):990-5
references.pmid: 9627331
references.citation: Radiology. 1972 Mar;102(3):701-4
references.pmid: 5060184
references.citation: J Nucl Med. 2006 Feb;47(2):287-97
references.pmid: 16455635
references.citation: Eur J Nucl Med Mol Imaging. 2008 May;35(5):976-83
references.pmid: 18188560
references.citation: J Nucl Med. 1962 Jul;3:332-4
references.pmid: 13869926
references.citation: Br J Radiol. 2005;78 Spec No 2:S103-11
references.pmid: 16306632
references.citation: Invest Radiol. 2006 Feb;41(2):185-8
references.pmid: 16428991
references.citation: J Med Imaging Radiat Oncol. 2008 Feb;52(1):24-8
references.pmid: 18373822
references.citation: Nuklearmedizin. 2003 Feb;42(1):25-30
references.pmid: 12601451
references.citation: Ultrasound Med Biol. 2008 Jul;34(7):1025-32
references.pmid: 18255215
references.citation: J Nucl Med. 2006 Jul;47(7):1102-6
references.pmid: 16818944
references.citation: J Comput Assist Tomogr. 2008 Mar-Apr;32(2):163-72
references.pmid: 18379296
references.citation: Eur Radiol. 2008 Apr;18(4):707-15
references.pmid: 17938936
references.citation: Rofo. 2005 Jun;177(6):788-95
references.pmid: 15902626
references.citation: Br J Urol. 1994 Jan;73(1):65-9
references.pmid: 8298901
references.citation: Curr Opin Urol. 2007 Jan;17(1):39-47
references.pmid: 17143110
references.citation: Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1065-73
references.pmid: 18200444
references.citation: Eur Urol. 2008 Dec;54(6):1354-62
references.pmid: 18374470
references.citation: Acta Radiol. 2008 Feb;49(1):107-20
references.pmid: 18210320
references.citation: J Urol. 1994 Nov;152(5 Pt 1):1520-5
references.pmid: 7523710
references.citation: J Urol. 1997 Mar;157(3):902-6
references.pmid: 9072596
references.citation: Anticancer Res. 2007 Nov-Dec;27(6C):4315-20
references.pmid: 18214038
references.citation: BJU Int. 2003 Jul;92(1):28-31
references.pmid: 12823378
references.citation: Rofo. 2008 Aug;180(8):746-52
references.pmid: 18512192
references.citation: Acta Radiol. 1990 Nov;31(6):597-600
references.pmid: 2278785
references.citation: Cancer Res. 2001 May 1;61(9):3599-603
references.pmid: 11325827
references.citation: J Nucl Med. 2002 Feb;43(2):181-6
references.pmid: 11850482
references.citation: Clin Radiol. 2008 Apr;63(4):387-95
references.pmid: 18325358
references.citation: Eur Urol. 2002 Jul;42(1):18-23
references.pmid: 12121724
references.citation: Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):18-23
references.pmid: 17891394
references.citation: Urol Clin North Am. 2006 Aug;33(3):329-37
references.pmid: 16829268
references.citation: Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):253-63
references.pmid: 17926036
references.citation: Eur Radiol. 2008 Jun;18(6):1281-91
references.pmid: 18270715
references.citation: Int J Urol. 2008 Jan;15(1):68-75; discussion 75
references.pmid: 18184177